ASK REDCHAT ANYTHING ABOUT INHIBIKASE THERAPEUTICS INC.
Inhibikase Therapeutics Inc. (NASDAQ: IKT)
Listen to this Section
$1.66
-0.0050
(
-0.30% )
347.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| IkT-001ProDetailsHematologic malignancies, Gastric cancer, Cancer |
Phase 3 |
| RisvodetinibDetailsParkinson's disease, Neurodegenerative disease |
Phase 2 |
| IkT-001ProDetailsCancer, Hematologic malignancies, Gastric cancer |
Phase 3 |
| Risvodetinib (IkT-148009)DetailsNeurodegenerative disease, Parkinson's disease |
Phase 2 |
Market Data
|
| Open |
$1.66 |
| Previous Close |
$1.66 |
| Volume |
347.0K |
| Market Cap |
$220.49M |
| Day Range |
$1.62 - $1.72 |
| 52 Week Range |
$1.33 - $2.26 |
| Shares Outstanding |
132.03M |
| Change % |
-0.30% |
| Net Change |
▼ -0.0050 |
| Insider Ownership |
-0.46% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
1,715,000.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-10-23 |
Buy |
365000.00 |
Munshi Amit |
| 2024-10-23 |
Buy |
145000.00 |
Kush Arvind |
| 2024-10-23 |
Buy |
1460000.00 |
Bellini Roberto |
| 2024-07-18 |
Sale |
-30000.00 |
Freeman Roy Lester |
| 2024-07-18 |
Sale |
-30000.00 |
BERMAN DENNIS N |
| 2024-07-18 |
Sale |
-30000.00 |
Dion Gisele |
| 2024-07-18 |
Sale |
-30000.00 |
GRINT PAUL C |
| 2024-04-03 |
Sale |
-45000.00 |
Werner Milton H. |
| 2024-04-02 |
Sale |
-90000.00 |
Lees-Rolfe Garth |